Lataa...

Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.

1 Phenylbutazone in doses of 50, 100, 200 and 300 mg/day has been given for four periods of 3 weeks to seven patients with rheumatoid arthritis. The trial was double-blind and the order of administration of doses was arranged to eliminate order and carry-over effects. 2 Before the trial and at the e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Orme, M, Holt, P J, Hughes, G R, Bulpitt, C J, Draffan, G H, Thorgeirsson, S S, Williams, F, Davies, D S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1976
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1428814/
https://ncbi.nlm.nih.gov/pubmed/788739
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!